Prevalence and Characteristics of Steatotic Liver Disease in Germany - Magnetic Resonance Imaging in the German National Cohort (NAKO)

Read full text
Authors: Marc-Nicolas von Itter, Elena Grune, Tobias Nonnenmacher, Stefan Rach, Martyna Flis, Tobias Haueise, Jakob Weiss, Hermann Brenner, Thomas Keil, Michael Roden, Matthias B. Schulze, Jeanette Esther Schulz-Menger
+9 more Henry Völzke, Norbert Stefan, Christopher L. Schlett, Hans-Ulrich Kauczor, Jürgen Machann, Fabian Bamberg, Johanna Nattenmüller, Tobias Norajitra, Susanne Rospleszcz
Cited by: 1
References: 41

Abstract

Abstract Background and Aims Steatotic liver disease (SLD) has high clinical and public health relevance. Robust population estimates of SLD and its subcategories are challenging due to the limitations of ultrasound measurements or non-invasive scores, particularly for low-grade steatosis. We aimed to quantify SLD prevalence using magnetic resonance imaging (MRI) in the population-based German National Cohort (NAKO). Methods Hepatic multi-echo Dixon MRI was performed at 5 dedicated study sites with identical setup across Germany. Liver fat (proton density fat fraction, PDFF), R2* as proxy for liver iron, and liver volume were assessed. The resulting data of N = 29’842 individuals (age range 20-72 years) were weighted by survey weights for regional representativeness, resulting in a sample of 50% women and a mean age of 45.6 years. SLD was defined as PDFF ≥ 5.75%, and sex-specific prevalence according to age, BMI, socioeconomic status and geographic region was calculated. Results Overall, SLD prevalence was 21.3% in women and 35.7% in men, and the majority were metabolic dysfunction-associated (MASLD, 89.3% of all SLD cases). Prevalence increased with age in a sex-specific pattern, suggesting potential menopausal effects in women. There was a relevant prevalence of SLD in individuals with normal weight (5.3% in women, 13.2% in men) and the age group

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Liver Diseases and Immunity

Publication details

Journal / source
medRxiv
Publisher
openRxiv
Publication date
1 June 2026
Language
EN
Document type
Preprint